Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections

The human parainfluenza viruses (hPIVs) and Respiratory Syncytial Virus (RSV) are the leading causes of serious respiratory illness in the human pediatric population. Despite decades of research, there are currently no licensed vaccines for either the hPIV or RSV pathogens. Here we describe the test...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Zhan, Xiaoyan, Slobod, Karen S., Krishnamurthy, Sateesh, Luque de Johnson, Laura E., Takimoto, Toru, Jones, Bart, Surman, Sherri, Russell, Charles, Portner, Allen, Hurwitz, Julia L.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2008
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2728217/
https://ncbi.nlm.nih.gov/pubmed/18499307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.04.022
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg